Allergy Immunotherapy Market Segmentation
Allergy Immunotherapy Treatment Outlook (USD Billion, 2019-2030)
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Allergy Immunotherapy Allergy Type Outlook (USD Billion, 2019-2030)
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Allergy Immunotherapy Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
North America Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
US Outlook (USD Billion, 2019-2030)
US Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
US Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
CANADA Outlook (USD Billion, 2019-2030)
CANADA Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
CANADA Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Europe Outlook (USD Billion, 2019-2030)
Europe Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Europe Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Germany Outlook (USD Billion, 2019-2030)
Germany Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Germany Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
France Outlook (USD Billion, 2019-2030)
France Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
France Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
UK Outlook (USD Billion, 2019-2030)
UK Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
UK Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
ITALY Outlook (USD Billion, 2019-2030)
ITALY Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
ITALY Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Â
SPAIN Outlook (USD Billion, 2019-2030)
Spain Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Spain Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Rest Of Europe Outlook (USD Billion, 2019-2030)
REST OF EUROPE Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
REST OF EUROPE Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Asia-Pacific Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
China Outlook (USD Billion, 2019-2030)
China Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
China Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Japan Outlook (USD Billion, 2019-2030)
Japan Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Japan Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
India Outlook (USD Billion, 2019-2030)
India Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
India Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Australia Outlook (USD Billion, 2019-2030)
Australia Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Australia Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Rest of Asia-Pacific Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Rest of the World Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Middle East Outlook (USD Billion, 2019-2030)
Middle East Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Middle East Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Africa Outlook (USD Billion, 2019-2030)
Africa Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Africa Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Latin America Outlook (USD Billion, 2019-2030)
Latin America Allergy Immunotherapy by Treatment
Sublingual Immunotherapy
Subcutaneous Immunotherapy
Specific Immunotherapy
Latin America Allergy Immunotherapy by Allergy Type
Allergic Rhinitis
Allergic Asthma
Peanut Allergy
Cat Allergy
Others
Specific Immunotherapy
Research Methodology on Allergy Immunotherapy Market
Introduction:
Allergy immunotherapy is a medical treatment that is used to treat an allergic response to particular substances, such as pollen, dust mites, or animal dander. The goal of immunotherapy is to decrease the patient's sensitization to the allergen, thus decreasing the severity and frequency of the allergic reactions. This type of treatment is usually administered at regular intervals, and the exact timeline depends on the individual patient's condition. It can take up to three years for a patient to see significant improvement in their symptoms. Furthermore, allergy immunotherapy is often used as a long-term solution for individuals who have difficulty controlling their allergies with other treatment methods or medications.
The growing prevalence of allergies worldwide and the increasing use of allergy immunotherapy products are some of the major factors driving the growth of the market. Furthermore, the launch of new and improved products and the availability of extensive reimbursement plans are also expected to drive the market further over the forecast period 2023 to 2030.
In this market research report, the global allergy immunotherapy market is segmented based on product type, route of administration, end-user, and region. The product type segment is further sub-segmented into sublingual immunotherapy, subcutaneous immunotherapy, and others. The route of administration segment is further sub-segmented into subcutaneous and oral. Additionally, the end-user segment is further categorized into hospitals, speciality clinics, and others.
Research Methodology:
The objective of this market research report is to study the global allergy immunotherapy market during the forecast period from 2023 to 2030. To understand the market dynamics, market trends, and other factors affecting the global allergy immunotherapy market, a comprehensive research methodology is followed. This study is conducted to analyze the market size in terms of value (USD Million). A systematic approach is followed, where the global allergy immunotherapy market is first segmented into several sub-segments and the related market dynamics were studied.
The research methodology involves primary and secondary data collection and analysis. Data is collected from the major key players operating in the global allergy immunotherapy market. The primary data sources include interviews and discussions with experts from manufacturers, suppliers, distributors, and end-user organizations operating in the global allergy immunotherapy market. The secondary data sources include various sources such as company websites, industry associations, and published reports. Additionally, a SWOT analysis is conducted to identify the strengths, weaknesses, opportunities, and threats that are associated with the global allergy immunotherapy market.
To estimate the global allergy immunotherapy market size and market shares, the market is segmented into various categories. The market size is estimated using bottom-up and top-down approaches, whereas the historical and current market data are used to analyze the market trends. Market estimations and forecasts are developed on a regional, sub-regional, and country-level basis.
The bottom-up approach is used to derive the global allergy immunotherapy market size by estimating the sales volume of each product type based on the revenue of key players operating in the market. Furthermore, the market is studied in terms of various routes of administration and end-users. Market estimations and forecasts were made for each segment based on sales or volume during the forecast period from 2023 to 2030. The data collected from primary and secondary sources is validated and verified by analyzing the views of various industry experts operating in the global allergy immunotherapy market.
Finally, market estimates and forecasts were validated through the triangulation method, where secondary and primary research data sets were compared with third-party data sets, such as technology blogs, industry associations, and news articles. This research methodology enables us to gather data and analyze trends across a wide range of factors and segments, including product type, route of administration, end-user, and region. The final data sets, once validated and verified, were used to develop the report and develop market estimates and forecasts.
1 Report Prologue
2 Market Introduction
2.1 Introduction 18
2.2 Scope of Study 18
2.3 Research Objective 19
2.4 Assumptions & Limitations 19
2.4.1 Assumptions 19
2.4.2 Limitations 19
2.5 Market Structure 20
3 Research Methodology
3.1 Research Process 21
3.2 Primary Research 22
3.3 Secondary Research 22
3.4 Market Size Estimation 22
3.5 Forecast Model 24
4 Market Dynamics
4.1 Introduction 25
4.2 Drivers 25
4.2.1 Launch of New sublingual Immunotherapies in emerging Economies will Drive the Growth of the Market 25
4.2.2 Major Players are introducing Several Allergen Immunotherapy Tablets (AITs) in Potential Markets 26
4.2.3 Increase in risk Factors Causing Allergies 26
4.2.4 Rising Screening for Allergy and reimbursement Scenario 26
4.3 Restraint 27
4.3.1 Restricted Healthcare Spending in underserved Market of Europe will Restrain the Growth 27
4.4 Opportunity 27
4.4.1 Allergy Immune Therapies will be Launched in the US. 27
4.5 Challenges 28
4.5.1 High Cost of Allergy Immunotherapy 28
4.6 Micro Economic Indicators 28
5 Market Factor Analysis
5.1 Porter’s Five Forces Model 30
5.1.1 Bargaining Power of Suppliers 31
5.1.2 Bargaining Power of Buyers 31
5.1.3 Threat of New Entrants 31
5.1.4 Threat of Substitutes 31
5.1.5 Intensity of Rivalry 31
5.2 Supply Chain Analysis 32
5.2.1 R&D 32
5.2.2 Parts Manufacturing 33
5.2.3 Distribution 33
5.2.4 Marketing & Sales 33
5.2.5 Post-Sales Monitoring 33
5.3 Pricing Analysis 33
5.4 Investment Opportunity Analysis 34
5.5 Merger and Acquisition Landscape 35
6 Allergy Immunotherapy Market, by Type of Therapy
6.1 Subcutaneous Immunotherapy (SCIT) 37
6.2 Sublingual Immunotherapy (SLIT) 38
7 Allergy Immunotherapy Market, by Types Of Allergies
7.1 Rhinitis 40
7.2 Asthma 40
7.3 Eye Allergy 41
7.4 Skin Allergy 41
8 Allergy Immunotherapy Market, by End User
8.1 Hospitals 43
8.2 Clinics 43
8.3 Diagnostic Centers 44
9 Global Allergy immunotherapy Market, by Region
9.1 Americas 46
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.1 North America 48
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.1.1 US 51
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.1.2 Canada 53
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2 Latin America 55
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.1 Brazil 57
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.2 Mexico 59
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.3 Argentina 61
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.4 Columbia 63
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.5 Chile 64
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.2.6 Rest of Latin America 66
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3 South America 67
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.1 Bolivia 70
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.2 Ecuador 73
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.3 Peru 75
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.4 Venezuela 77
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.1.3.5 Uruguay 78
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2 Europe 80
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1 Western Europe 82
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.1 Germany 84
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.2 France 86
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.3 UK 88
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.4 Italy 90
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.5 Spain 92
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.6 Russia 94
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.1.7 Rest of Western Europe 96
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.2 Central Europe 97
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.2.1 Switzerland 99
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.2.2 Slovenia 101
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.3 Eastern Europe 103
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.4 Greece 105
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.2.5 Rest of Eastern Europe 107
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3 Asia-Pacific 109
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.1 Japan 111
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.2 China 113
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.3 India 115
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.4 South Korea 117
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.5 Australia 118
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.3.6 New Zealand 120
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.4 Middle East & Africa 121
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.5 Middle East 124
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
9.6 Africa 125
Allergy Immunotherapy Market, by Type of Therapy
Allergy Immunotherapy Market, by Types Of Allergies
Allergy Immunotherapy Market, by End User
10 Company Landscape
10.1 Introductions 127
11 Company Profile
11.1 ALK Abello A/S 129
11.1.1 Overview 129
11.1.2 Product/Business Overview 129
11.1.3 Financial Overview 129
11.1.4 Key Development 131
11.1.5 SWOT Analysis 131
11.2 Allergy Therapeutics 132
11.2.1 Company Overview 132
11.2.2 Product/Business Segment Overview 132
11.2.3 Financial Overview 132
11.2.4 Key Development 133
11.2.5 SWOT Analysis 134
11.3 Circassia 135
11.3.1 Company Overview 135
11.3.2 Product/Business Segment Overview 135
11.3.3 Financial Overview 135
11.3.4 Key Development 136
11.3.5 SWOT Analysis 137
11.4 DBV Technologies 138
11.4.1 Company Overview 138
11.4.2 Product/Business Segment Overview 138
11.4.3 Financial Overview 138
11.4.4 Key Development 139
11.4.5 SWOT Analysis 139
11.5 Stallergenes Greer 140
11.5.1 Company Overview 140
11.5.2 Product/Business Segment Overview 140
11.5.3 Financial Overview 140
11.5.4 Key Development 142
11.5.5 SWOT Analysis 142
11.6 Merck KGaA (Allergopharma) 143
11.6.1 Company Overview 143
11.6.2 Product/Business Segment Overview 143
11.6.3 Financial Overview 144
11.6.4 Key Development 145
11.6.5 SWOT Analysis 145
11.7 HAL Allergy Group 146
11.7.1 Company Overview 146
11.7.2 Product/Business Segment Overview 146
11.7.3 Financial Overview 146
11.7.4 Key Development 146
11.7.5 SWOT Analysis 147
12 Conclusion
12.1 Key Findings 148
12.1.1 From CEO’s View Point 148
12.2 Key Companies To Watch 148
13 Appendix
13.1 Discussion Blue Print 149
14 List of Tables
TABLE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USDMILLION 2023-2030 36
TABLE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY (SCIT) USDMILLION 2023-2030 37
TABLE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SUBLINGUAL IMMUNOTHERAPY USDMILLION 2023-2030 38
TABLE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPES OF ALLERGIES USD MILLION 2023-2030 39
TABLE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR RHINITIS USD MILLION 2023-2030 40
TABLE 6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR ASTHMA USD MILLION 2023-2030 40
TABLE 7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR EYE ALLERGY USD MILLION 2023-2030 41
TABLE 8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR SKIN ALLERGY USD MILLION 2023-2030 41
TABLE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 42
TABLE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR HOSPITALS USD MILLION 2023-2030 43
TABLE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR CLINICS USD MILLION 2023-2030 43
TABLE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET FOR DIAGNOSTIC CENTERS USD MILLION 2023-2030 44
TABLE 13 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 45
TABLE 14 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 46
TABLE 15 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 47
TABLE 16 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 47
TABLE 17 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 48
TABLE 18 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2023-2030 48
TABLE 19 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 49
TABLE 20 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 50
TABLE 21 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 50
TABLE 22 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 51
TABLE 23 US ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 51
TABLE 24 US ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 53
TABLE 25 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 53
TABLE 26 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 54
TABLE 27 CANADA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 54
TABLE 28 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2023-2030 55
TABLE 29 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 56
TABLE 30 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 56
TABLE 31 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 57
TABLE 32 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 57
TABLE 33 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 58
TABLE 34 BRAZIL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 58
TABLE 35 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 59
TABLE 36 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 59
TABLE 37 MEXICO ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 61
TABLE 38 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 61
TABLE 39 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 62
TABLE 40 ARGENTINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 62
TABLE 41 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 63
TABLE 42 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 63
TABLE 43 COLUMBIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 64
TABLE 44 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 64
TABLE 45 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 65
TABLE 46 CHILE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 65
TABLE 47 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 66
TABLE 48 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 66
TABLE 49 REST OF LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 67
TABLE 50 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2023-2030 67
TABLE 51 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 68
TABLE 52 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 69
TABLE 53 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 69
TABLE 54 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 70
TABLE 55 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 70
TABLE 56 BOLIVIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 72
TABLE 57 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 73
TABLE 58 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 73
TABLE 59 ECUADOR ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 75
TABLE 60 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 75
TABLE 61 PERU ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 76
TABLE 62 PERU ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 76
TABLE 63 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 77
TABLE 64 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 77
TABLE 65 VENEZUELA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 78
TABLE 66 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 78
TABLE 67 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 79
TABLE 68 URUGUAY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 79
TABLE 69 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 80
TABLE 70 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 81
TABLE 71 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 81
TABLE 72 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 82
TABLE 73 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY USD MILLION 2023-2030 82
TABLE 74 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 83
TABLE 75 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 84
TABLE 76 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 84
TABLE 77 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 85
TABLE 78 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 85
TABLE 79 GERMANY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 86
TABLE 80 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 86
TABLE 81 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 87
TABLE 82 FRANCE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 87
TABLE 83 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 88
TABLE 84 UK ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 88
TABLE 85 UK ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 90
TABLE 86 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 90
TABLE 87 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 91
TABLE 88 ITALY ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 91
TABLE 89 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 92
TABLE 90 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 92
TABLE 91 SPAIN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 94
TABLE 92 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 94
TABLE 93 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 95
TABLE 94 RUSSIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 95
TABLE 95 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 96
TABLE 96 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 96
TABLE 97 REST OF WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 97
TABLE 98 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2023-2030 97
TABLE 99 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 98
TABLE 100 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 99
TABLE 101 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 99
TABLE 102 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 100
TABLE 103 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 100
TABLE 104 SWITZERLAND ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 100
TABLE 105 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 101
TABLE 106 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 102
TABLE 107 SLOVENIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 102
TABLE 108 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS USD MILLION 2023-2030 103
TABLE 109 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 103
TABLE 110 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 104
TABLE 111 EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 104
TABLE 112 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 105
TABLE 113 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 105
TABLE 114 GREECE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 107
TABLE 115 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 107
TABLE 116 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 108
TABLE 117 REST OF EASTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 108
TABLE 118 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 109
TABLE 119 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 110
TABLE 120 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 110
TABLE 121 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 111
TABLE 122 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 111
TABLE 123 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 112
TABLE 124 JAPAN ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 112
TABLE 125 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 113
TABLE 126 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 113
TABLE 127 CHINA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 115
TABLE 128 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 115
TABLE 129 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 116
TABLE 130 INDIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 116
TABLE 131 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 117
TABLE 132 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 117
TABLE 133 SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 118
TABLE 134 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 118
TABLE 135 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 119
TABLE 136 AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 119
TABLE 137 REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 120
TABLE 138 NEW ZEALAND ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 120
TABLE 139 NEW ZEALAND PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 121
TABLE 140 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 121
TABLE 141 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 122
TABLE 142 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 123
TABLE 143 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 123
TABLE 144 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 124
TABLE 145 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 124
TABLE 146 MIDDLE EAST ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 125
TABLE 147 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPIES USD MILLION 2023-2030 125
TABLE 148 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY USD MILLION 2023-2030 126
TABLE 149 AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 126
TABLE 150 ALK-ABELLĂ“ A/S: KEY DEVELOPMENT 131
TABLE 151 ALLERGY THERAPEUTICS : KEY DEVELOPMENT 133
TABLE 152 CIRCASSIA : KEY DEVELOPMENT 136
TABLE 153 DBV TECHNOLOGIES: KEY DEVELOPMENT 139
TABLE 154 STALLERGENES GREER: KEY DEVELOPMENT 142
TABLE 155 MERCK KGAA: KEY DEVELOPMENT 145
TABLE 156 HAL ALLERGY GROUP: KEY DEVELOPMENT 146
15 List of Figures
FIGURE 1 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY, 2020 (%) 15
FIGURE 2 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGY, 2020 (%) 16
FIGURE 3 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS, 2020 (%) 16
FIGURE 4 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION, 2020 (%) 17
FIGURE 5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: MARKET STRUCTURE 20
FIGURE 6 RESEARCH PROCESS 21
FIGURE 7 PORTERS FIVE FORCES MODEL 30
FIGURE 8 SUPPLY CHAIN: ALLERGY IMMUNOTHERAPY 32
FIGURE 9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF THERAPY USD MILLION 2023-2030 36
FIGURE 10 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF ALLERGIES USD MILLION 2023-2030 39
FIGURE 11 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY END USERS USD MILLION 2023-2030 42
FIGURE 12 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 45
FIGURE 13 AMERICAS ALLERGY IMMUNOTHERAPY MARKET, BY REGION MARKET SHARE 2020 (%) 46
FIGURE 14 NORTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 49
FIGURE 15 LATIN AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 55
FIGURE 16 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY MARKET SHARE 2020 (%) 68
FIGURE 17 EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 80
FIGURE 18 WESTERN EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY COUNTRY MARKET SHARE 2020 (%) 83
FIGURE 19 CENTRAL EUROPE ALLERGY IMMUNOTHERAPY MARKET, BY REGIONS MARKET SHARE 2020 (%) 98
FIGURE 20 ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET, BY REGION USDMILLION 2023-2030 109
FIGURE 21 MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET, BY REGION USD MILLION 2023-2030 122
FIGURE 22 GLOBAL ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 127
FIGURE 23 AMERICAS ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128
FIGURE 24 EUROPE ALLERGY IMMUNOTHERAPY MARKET: COMPANY SHARE ANALYSIS 128
FIGURE 25 ALK-ABELLĂ“ A/S: RECENT FINANCIAL 129
FIGURE 26 ALK-ABELLĂ“ A/S: BUSINESS REVENUE MIX (2015) 129
FIGURE 27 ALK-ABELLĂ“ A/S: GEOGRAPHIC REVENUE MIX 130
FIGURE 28 ALK-ABELLĂ“ A/S: SWOT ANALYSIS 131
FIGURE 29 ALLERGY THERAPEUTICS : RECENT FINANCIAL 132
FIGURE 30 ALLERGY THERAPEUTICS : GEOGRAPHIC REVENUE MIX 133
FIGURE 31 ALLERGY THERAPEUTICS : SWOT ANALYSIS 134
FIGURE 32 CIRCASSIA : RECENT FINANCIAL 135
FIGURE 33 CIRCASSIA : GEOGRAPHIC REVENUE MIX 136
FIGURE 34 CIRCASSIA : SWOT ANALYSIS 137
FIGURE 35 DBV TECHNOLOGIES: RECENT FINANCIAL 138
FIGURE 36 DBV TECHNOLOGIES: SWOT ANALYSIS 139
FIGURE 37 STALLERGENES GREER: RECENT FINANCIAL 140
FIGURE 38 STALLERGENES GREER: BUSINESS REVENUE MIX (2015) 140
FIGURE 39 STALLERGENES GREER: GEOGRAPHIC REVENUE MIX 141
FIGURE 40 STALLERGENES GREER: SWOT ANALYSIS 142
FIGURE 41 MERCK KGAA: RECENT FINANCIAL 144
FIGURE 42 MERCK KGAA: GEOGRAPHIC REVENUE MIX 144
FIGURE 43 MERCK KGAA: SWOT ANALYSIS 145
FIGURE 44 HAL ALLERGY GROUP: SWOT ANALYSIS 147
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
